This is why I think the 700mg data I so important, knowing what is going on so dosing and guidance for how and when to use leronlimab. The idea that 700 is expected to double the effect of 350 is kind of useless. How do you make a p3 protocol without knowing how to access the patients condition and the receptor occupancy? We now have a very good idea of what the label will say as an approved drug so doctors know more than just more is better.